The transcatheter embolization and occlusion devices market size has grown rapidly in recent years. It will grow from $5.23 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to expansion of interventional radiology procedures, rising prevalence of vascular disorders, increased availability of catheter-based therapies, growing adoption of minimally invasive treatments, improvements in imaging-guided intervention techniques.
The transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $8.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for targeted embolization therapies, rising adoption of advanced embolic materials, expansion of oncology and neurointerventional procedures, growing focus on precision medicine, increasing investments in interventional healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising demand for advanced liquid embolic agents, growing use of detachable and coated coils, expansion of image-guided interventional techniques, enhanced focus on precision occlusion technologies.
The growing demand for minimally invasive surgical techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries use small incisions or robotic-assisted tools to access internal structures, minimizing tissue damage and resulting in reduced trauma, shorter recovery times, less postoperative pain, and a lower risk of complications. The rising preference for these procedures is driven by advancements in surgical technology, increased patient awareness of less-invasive options, and improved clinical outcomes. Transcatheter embolization and occlusion devices facilitate such minimally invasive interventions by enabling targeted, catheter-based treatments with high precision and minimal disruption to surrounding tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology company, worldwide da Vinci procedures in 2024 increased by approximately 17% compared with 2023, and are expected to grow by 13% to 16% in 2025. Therefore, the increasing adoption of minimally invasive techniques is driving the growth of the transcatheter embolization and occlusion devices market.
Major companies operating in the transcatheter embolization and occlusion devices market are focusing on developing advanced solutions, such as liquid embolic systems, to address the growing demand for minimally invasive vascular interventions and precise management of arterial hemorrhage. A liquid embolic system is a non-adhesive, polymer-based embolization technology delivered through a microcatheter that solidifies upon contact with blood, enabling controlled occlusion of abnormal or damaged vessels while offering deeper penetration and greater accuracy than conventional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, initiated clinical evaluation of its Onyx Liquid Embolic System (LES) through an IDE study for embolization of arterial hemorrhage in the peripheral vasculature. The system uses an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and combined with tantalum powder for radiopacity, allowing physicians to visualize and precisely control delivery in real time. Upon solvent diffusion, it forms a cohesive embolus that achieves targeted vessel occlusion with reduced risk of catheter entrapment. Designed for active peripheral arterial bleeding, this system enhances precision, supports minimally invasive workflows, and broadens therapeutic options for interventional specialists.
In February 2025, Stryker Corporation, a US-based healthcare technology company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aimed to expand its footprint in the rapidly growing peripheral vascular intervention market and enhance its portfolio with advanced venous thrombectomy technologies. Inari Medical Inc. is a US-based medical device company specializing in minimally invasive mechanical thrombectomy systems and the development of transcatheter mechanical thrombectomy devices.
Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular.
North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transcatheter embolization and occlusion devices market by increasing costs of imported specialty polymers, metal alloys, microcatheters, imaging-compatible components, and precision manufacturing equipment. Hospitals and interventional centers in North America and Europe are most affected due to reliance on imported high-performance medical materials, while Asia-Pacific faces cost pressure on device exports. These tariffs are raising procedure costs and affecting procurement budgets. However, they are also encouraging localized device manufacturing, regional material sourcing, and innovation in cost-effective embolization and occlusion technologies.
The transcatheter embolization and occlusion devices market research report is one of a series of new reports that provides transcatheter embolization and occlusion devices market statistics, including transcatheter embolization and occlusion devices industry global market size, regional shares, competitors with a transcatheter embolization and occlusion devices market share, detailed transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter embolization and occlusion devices industry. This transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transcatheter Embolization and Occlusion Devices are medical instruments employed in minimally invasive procedures to halt blood flow in specific regions of the body. These devices are introduced via a catheter, a slender, flexible tube inserted into the vascular system. The primary objective of these interventions is to address various medical conditions by obstructing blood supply to particular tissues or organs.
The principal types of transcatheter embolization and occlusion devices include coil and non-coil variants. Coil devices are small, wire-like structures utilized in transcatheter embolization procedures to obstruct blood flow to targeted areas, often employed in the treatment of aneurysms or to impede blood flow to tumors. They find applications across domains such as peripheral vascular disease, oncology, neurology, urology, among others, and are utilized by end-users including hospitals, ambulatory surgical centers, clinics, and others.
The transcatheter embolization and occlusion devices market consists of sales of microspheres, gelatin sponges, and coil-assisted detachable balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $8.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for targeted embolization therapies, rising adoption of advanced embolic materials, expansion of oncology and neurointerventional procedures, growing focus on precision medicine, increasing investments in interventional healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising demand for advanced liquid embolic agents, growing use of detachable and coated coils, expansion of image-guided interventional techniques, enhanced focus on precision occlusion technologies.
The growing demand for minimally invasive surgical techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries use small incisions or robotic-assisted tools to access internal structures, minimizing tissue damage and resulting in reduced trauma, shorter recovery times, less postoperative pain, and a lower risk of complications. The rising preference for these procedures is driven by advancements in surgical technology, increased patient awareness of less-invasive options, and improved clinical outcomes. Transcatheter embolization and occlusion devices facilitate such minimally invasive interventions by enabling targeted, catheter-based treatments with high precision and minimal disruption to surrounding tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology company, worldwide da Vinci procedures in 2024 increased by approximately 17% compared with 2023, and are expected to grow by 13% to 16% in 2025. Therefore, the increasing adoption of minimally invasive techniques is driving the growth of the transcatheter embolization and occlusion devices market.
Major companies operating in the transcatheter embolization and occlusion devices market are focusing on developing advanced solutions, such as liquid embolic systems, to address the growing demand for minimally invasive vascular interventions and precise management of arterial hemorrhage. A liquid embolic system is a non-adhesive, polymer-based embolization technology delivered through a microcatheter that solidifies upon contact with blood, enabling controlled occlusion of abnormal or damaged vessels while offering deeper penetration and greater accuracy than conventional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, initiated clinical evaluation of its Onyx Liquid Embolic System (LES) through an IDE study for embolization of arterial hemorrhage in the peripheral vasculature. The system uses an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and combined with tantalum powder for radiopacity, allowing physicians to visualize and precisely control delivery in real time. Upon solvent diffusion, it forms a cohesive embolus that achieves targeted vessel occlusion with reduced risk of catheter entrapment. Designed for active peripheral arterial bleeding, this system enhances precision, supports minimally invasive workflows, and broadens therapeutic options for interventional specialists.
In February 2025, Stryker Corporation, a US-based healthcare technology company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aimed to expand its footprint in the rapidly growing peripheral vascular intervention market and enhance its portfolio with advanced venous thrombectomy technologies. Inari Medical Inc. is a US-based medical device company specializing in minimally invasive mechanical thrombectomy systems and the development of transcatheter mechanical thrombectomy devices.
Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular.
North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transcatheter embolization and occlusion devices market by increasing costs of imported specialty polymers, metal alloys, microcatheters, imaging-compatible components, and precision manufacturing equipment. Hospitals and interventional centers in North America and Europe are most affected due to reliance on imported high-performance medical materials, while Asia-Pacific faces cost pressure on device exports. These tariffs are raising procedure costs and affecting procurement budgets. However, they are also encouraging localized device manufacturing, regional material sourcing, and innovation in cost-effective embolization and occlusion technologies.
The transcatheter embolization and occlusion devices market research report is one of a series of new reports that provides transcatheter embolization and occlusion devices market statistics, including transcatheter embolization and occlusion devices industry global market size, regional shares, competitors with a transcatheter embolization and occlusion devices market share, detailed transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter embolization and occlusion devices industry. This transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transcatheter Embolization and Occlusion Devices are medical instruments employed in minimally invasive procedures to halt blood flow in specific regions of the body. These devices are introduced via a catheter, a slender, flexible tube inserted into the vascular system. The primary objective of these interventions is to address various medical conditions by obstructing blood supply to particular tissues or organs.
The principal types of transcatheter embolization and occlusion devices include coil and non-coil variants. Coil devices are small, wire-like structures utilized in transcatheter embolization procedures to obstruct blood flow to targeted areas, often employed in the treatment of aneurysms or to impede blood flow to tumors. They find applications across domains such as peripheral vascular disease, oncology, neurology, urology, among others, and are utilized by end-users including hospitals, ambulatory surgical centers, clinics, and others.
The transcatheter embolization and occlusion devices market consists of sales of microspheres, gelatin sponges, and coil-assisted detachable balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Transcatheter Embolization and Occlusion Devices Market Characteristics
3. Transcatheter Embolization and Occlusion Devices Market Supply Chain Analysis
4. Global Transcatheter Embolization and Occlusion Devices Market Trends and Strategies
5. Transcatheter Embolization and Occlusion Devices Market Analysis of End Use Industries
7. Global Transcatheter Embolization and Occlusion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Transcatheter Embolization and Occlusion Devices Total Addressable Market (TAM) Analysis for the Market
9. Transcatheter Embolization and Occlusion Devices Market Segmentation
10. Transcatheter Embolization and Occlusion Devices Market Regional and Country Analysis
11. Asia-Pacific Transcatheter Embolization and Occlusion Devices Market
12. China Transcatheter Embolization and Occlusion Devices Market
13. India Transcatheter Embolization and Occlusion Devices Market
14. Japan Transcatheter Embolization and Occlusion Devices Market
15. Australia Transcatheter Embolization and Occlusion Devices Market
16. Indonesia Transcatheter Embolization and Occlusion Devices Market
17. South Korea Transcatheter Embolization and Occlusion Devices Market
18. Taiwan Transcatheter Embolization and Occlusion Devices Market
19. South East Asia Transcatheter Embolization and Occlusion Devices Market
20. Western Europe Transcatheter Embolization and Occlusion Devices Market
21. UK Transcatheter Embolization and Occlusion Devices Market
22. Germany Transcatheter Embolization and Occlusion Devices Market
23. France Transcatheter Embolization and Occlusion Devices Market
24. Italy Transcatheter Embolization and Occlusion Devices Market
25. Spain Transcatheter Embolization and Occlusion Devices Market
26. Eastern Europe Transcatheter Embolization and Occlusion Devices Market
27. Russia Transcatheter Embolization and Occlusion Devices Market
28. North America Transcatheter Embolization and Occlusion Devices Market
29. USA Transcatheter Embolization and Occlusion Devices Market
30. Canada Transcatheter Embolization and Occlusion Devices Market
31. South America Transcatheter Embolization and Occlusion Devices Market
32. Brazil Transcatheter Embolization and Occlusion Devices Market
33. Middle East Transcatheter Embolization and Occlusion Devices Market
34. Africa Transcatheter Embolization and Occlusion Devices Market
36. Transcatheter Embolization and Occlusion Devices Market Competitive Landscape and Company Profiles
37. Transcatheter Embolization and Occlusion Devices Market Other Major and Innovative Companies
40. Transcatheter Embolization and Occlusion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Transcatheter Embolization And Occlusion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses transcatheter embolization and occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for transcatheter embolization and occlusion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcatheter embolization and occlusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Coil; Non-Coil2) By Application: Peripheral Vascular Disease; Oncology; Neurology; Urology; Other Applications
3) By End User: Hospitals; Ambulatory Surgical Centers; Clinics; Other End Users
Subsegments:
1) By Coil: Bare Metal Coil; Surface Coated Coil; Detachable Coil2) By Non-Coil: Gelatin Sponge; Liquid Embolic Agents; Spheres And Particles
Companies Mentioned: Johnson & Johnson Services Inc.; Abbott Laboratories; Medtronic Inc.; Stryker Corporation; Boston Scientific Corporation; Terumo Corporation; Teleflex Incorporated; Cook Medical; Merit Medical Systems Inc.; Penumbra Inc.; Sirtex Medical Limited; Cordis Corporation; pfm medical ag; Micro Interventional Devices Inc.; Acandis GmbH; Metactive Medical Inc.; Balt Group; Kaneka Medix Corporation; Shape Memory Medical Inc.; Boston Scientific Neurovascular
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Transcatheter Embolization and Occlusion Devices market report include:- Johnson & Johnson Services Inc.
- Abbott Laboratories
- Medtronic Inc.
- Stryker Corporation
- Boston Scientific Corporation
- Terumo Corporation
- Teleflex Incorporated
- Cook Medical
- Merit Medical Systems Inc.
- Penumbra Inc.
- Sirtex Medical Limited
- Cordis Corporation
- pfm medical ag
- Micro Interventional Devices Inc.
- Acandis GmbH
- Metactive Medical Inc.
- Balt Group
- Kaneka Medix Corporation
- Shape Memory Medical Inc.
- Boston Scientific Neurovascular
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.79 Billion |
| Forecasted Market Value ( USD | $ 8.33 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
